Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel compounds described by Japan Energy for lipid disorders

July 20, 1998

LY-117018 is fully protective during the later slow phase of bone loss

July 20, 1998

Lilly describes several further series of estrogen receptor modulators

July 17, 1998

Genzyme General and Pharming to collaborate on Pompe's disease treatment

July 17, 1998

Genetronics develops TDD method for treating ED, seeks partners to carry on

July 16, 1998

Amylin completes enrollment in U.S. for phase III pramlintide studies

July 16, 1998

Vasomax NDA submitted for FDA review

July 16, 1998

Lilly describes serotonergic agents for treating obesity, CNS disorders

July 15, 1998

INVICORP approved for launch in Denmark

July 15, 1998

Vivus seeks partner to promote Muse in the U.S.

July 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...